Ir-CPI

N/A

Report date: 2025/05/28 16:57:17
First In Class

Base Information

Drug NameIr-CPI
Drug Alias NameIr-CPIBIOX-101
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionCoagulation factor XII inhibitorsFactor XIa inhibitorsSerine protease inhibitors
TargetsCoagulation factor XIICoagulation factor XISerine protease
Therapy Area/IndicationsCerebral Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFree University Of Brussels
China Registration ClassN/A

Develop Information

Active CompaniesBioxodes SA
Inactive CompaniesN/A
Active IndicationsCerebral Hemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A